Predictivity of Human Telomerase Reverse Transcriptase (h-TERT) in Oral Squamous Cell Carcinoma: Immunohistochemical Study
Eman Mosaad
Oral Pathology Department, Faculty of Dentistry, Mansoura University, Egypt.
Heba Ahmed Elhendawy *
Oral Pathology Department, Faculty of Dentistry, Mansoura University, Egypt.
Mina Mahfouz Elias Shenouda
Pathology Department, Faculty of Medicine, Mansoura University, Egypt.
Nadia Abbas Ibrahim El-sissy
Oral Pathology Department, Faculty of Dentistry, Mansoura University, Egypt.
*Author to whom correspondence should be addressed.
Abstract
Aims: Determine the potential role of h-TERT as a prognostic marker for oral squamous cell carcinoma by evaluating its immunohistochemical expression in different OSCC histologic grades in comparison with normal oral mucosa.
Study Design: A retrospective study.
Place and Duration: Oncology Center, Mansoura University, and Oral Pathology Department, Faculty of Dentistry, Mansoura University. The worked sample selected from the years (2015-2019).
Methodology: Our study was accomplished on 30 OSCC cases and a control group of normal oral mucosa. Histopathologic grading of OSCCs was made using the WHO grade and Anneroth`s grading systems. Immunohistochemical expression of h-TERT was assessed in relation to different clinicopathological parameters. The data was analyzed using Pearson`s chi-square test to compare the differences between groups. Spearman's correlation co-efficiency test was used to test the association between different variables. A P value ≤ 0.05 was considered to be statistically significant.
Results: A significant increased h-TERT expression was recorded from normal to OSCC groups (P=0.000). Additionally, elevated h-TERT expression was significantly correlated with the higher carcinoma histologic grade (P =0.025). There were high statistically significant differences in h-TERT expression concerning the parameters; Anneroth pattern of invasion (P= 0.049), depth of invasion (DOI, P=0.024), and lymphoplasmacytic infiltration (LPI, P=0.009). There were no statistically significant differences in h-TERT immunoexpression considering the clinical parameters; patient age, gender, anatomical sites, clinical shape of lesion, T, N, M, and TNM stages (Chi-square test, P values were > 0.05).
Conclusions: Increased h-TERT immunoexpression from normal to OSCC groups suggests its involvement in malignant transformation. Additionally, the significant differential expression of h-TERT among different OSCC histologic grades signaling its valuable use as a biomarker for assessing the cellular malignant progression of oral carcinomas, but unreliable as a clinical tumor progression marker. Moreover, the significant correlation of h-TERT expression with LPI, DOI and pattern of invasion indicating its possible reliable role in tumor host relation during multistage carcinogenesis.
Keywords: Oral squamous cell carcinoma, human telomerase reverse transcriptase, immunohistochemistry, predictive marker
How to Cite
References
Coletta RD, Yeudall WA, Salo T. Grand challenges in oral cancers. Frontiers in oral health. 2020;1:3.
Regezi Joseph A, James Sciubba RCJ. Oral pathology: Clinical pathologic correlations, 7th ed. In: chapter 2 :ulcerative condition. 7th editio. 2017;59.
Shafer Hine L. Shafer’s textbook in oral pathology. In: Sivapathasundharam B, editor. chapter 5 : Epithelial neoplasms of oral cavity [Internet]. 9th editio. 2020;169,159. Available:https://books.google.com.eg/books?id=WnhtAwAAQBAJ&printsec=frontcover&dq=inauthor:%22B+Sivapathasundharam%22&hl=ar&sa=X&redir_esc=y#v=onepage&q&f=false
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Nocini R, Lippi G, Mattiuzzi C. Biological and epidemiologic updates on lip and oral cavity cancers. Ann Cancer Epidemiol. 2020;4(1):1-6.
Fan HC, Chang FW, Tsai JD, Lin KM, Chen CM, Lin SZ, Liu CA, Harn HJ. Telomeres and cancer. Life. 2021; 11(12):1405.
Victorelli S, Passos JF. EBioMedicine Telomeres and Cell Senescence - Size Matters Not. EBioMedicine [Internet]. 2017;21:14–20. Available:http://dx.doi.org/10.1016/j.ebiom.2017.03.027
Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome medicine. 2016;8:1-8.
Rosen J, Jakobs P, Ale-Agha N, Altschmied J, Haendeler J. Non-canonical functions of Telomerase Reverse Transcriptase–Impact on redox homeostasis. Redox Biology. 2020; 34:101543.
Wang K, Wang RL, Liu JJ, Zhou J, Li X, Hu WW, Jiang WJ, Hao NB. The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis. Medicine. 2018;97(35).
Yuan X, Yuan H, Zhang N, Liu T, Xu D. Thyroid carcinoma‐featured telomerase activation and telomere maintenance: Biology and translational/clinical significance. Clinical and Translational Medicine. 2022;12(11):e1111.
Donati B, Ciarrocchi A. Telomerase and telomeres biology in thyroid cancer. Int J Mol Sci. 2019;20(12):1–17.
in der Stroth L, Tharehalli U, Günes C, Lechel A. Telomeres and telomerase in the development of liver cancer. Cancers. 2020;12(8):2048.
Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.
Gomatou G, Masaoutis C, Vamvakaris I, Kotteas E, Bouros E, Tzilas V, Bouros D. Differential immunohistochemical expression of hTERT in lung cancer patients with and without idiopathic pulmonary fibrosis. Pulmonology; 2022.
Siraj AK, Bu R, Iqbal K, Parvathareddy SK, Siraj N, Siraj S, Diaz MR, Rala DR, Benito AD, Sabido MA, Al-Rasheed M. Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population. Genomics. 2020; 112(2):1746-53.
Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res. 1987;95(3):229–49.
Boscolo-Rizzo P, Da Mosto MC, Rampazzo E, Giunco S, Del Mistro A, Menegaldo A, et al. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications. Cancer Metastasis Rev. 2016;35(3):457–74.
Raju K L, Haragannavar VC, Patil S, Rao RS, Nagaraj T, Augustine D, et al. Expression of hTERT in oral submucous fibrosis and oral squamous cell carcinoma – An immunohistochemical analysis. Pathol Oncol Res. 2020; 26(3): 1573–82.
Wan S, Wan F, Wan P, Wan J, He X, Liu F, et al. The relation of microsatellite instability to expression of hTERT in human gastric carcinoma. 2019;12:2257–63.
Rai A, Naikmasur VG, Sattur A. Quantification of telomerase activity in normal oral mucosal tissue and oral squamous cell carcinoma. Indian J Med Paediatr Oncol. 2016;37(3):183–8.
Haraguchi K, Habu M, Yada N, Sasaguri M, Yoshioka I, Tominaga K. Human telomerase reverse transcriptase protein expression is associated with survival in patients with oral squamous cell carcinoma. Int J Clin Exp Pathol [Internet]. 2022;15(1):29–37 Available:http://www.ncbi.nlm.nih.gov/pubmed/35145581%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8822205
Raghunandan B, Sanjai K, Kumaraswamy J, Papaiah L, Pandey B, Jyothi B. Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study. J Oral Maxillofac Pathol. 2016; 20(1):96–101.
Kohli JS, Mir H, Wasif A, Chong H, Akhras V, Kumar R, et al. ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression. Oncotarget. 2017;8(61):104408–17.
Bustos BDU, Torralba AS, Poveda PM, Simó GP, Farinos JS, Ros ML, et al. Telomerase Expression in a Series of Melanocytic Neoplasms. Actas Dermosifiliogr. 2019;110(3):212–9.
Zou Y, Cong Y sheng, Zhou J. Implications of telomerase reverse transcriptase in tumor metastasis. BMB Rep. 2020; 53(9):458–65.
Prasad RR, Mishra DK, Kumar M, Yadava PK. Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation. Heliyon. 2022;8(1).
Xian S, Dosset M, Castro A, Carter H, Zanetti M. Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer. PNAS Nexus [Internet]. 2023; 2(3):1–13.